Book Online Tickets for Recognizing and Responding to -Red Flags, Palo Alto.  Sponsors need to comply with various legal requirements for drug product development. These include communications with Federal and State Regulatory agencies. The post-marketing requirements include more functional areas of the company such as

Recognizing and Responding to -Red Flags- in Clinical Operations

 

  • One Dial-in One Attendee

    Sale Date Ended

    USD 249
    Sold Out
  • Group-Max 10 Attendees-Location

    Sale Date Ended

    USD 629
    Sold Out
  • 1x Person - Unlimited viewing for 6 Months

    Sale Date Ended

    USD 299
    Sold Out
  • One CD-USB is for usage in one location only

    Sale Date Ended

    USD 399
    Sold Out
  • Live + Recorded Version

    Sale Date Ended

    USD 429
    Sold Out
  • Live + Training CD-USB

    Sale Date Ended

    USD 529
    Sold Out

Invite friends

Contact Us

Page Views : 3

About The Event

 Sponsors need to comply with various legal requirements for drug product development. These include communications with Federal and State Regulatory agencies. The post-marketing requirements include more functional areas of the company such as sales and marketing, medical affairs, and external spokespersons.

Why Should You Attend:

Attend this webinar to learn the regulatory obligations and related timing for those activities.

Includes details regarding:

  • Drug listing
  • Pediatric studies
  • Advertising submissions (US)
  • Annual Reports
  • Periodic Safety Update Reports
  • Pharmacovigilance
  • Supplements/Variations
  • Renewals (EU)
  • Commitments
  • Interaction with other Agencies
 

Areas Covered in the Webinar:

  • FDA Requirements
    • Regulatory
    • Pharmacovigilance
    • Manufacturing
    • Sales & Marketing
    • Medical Affairs
    • Quality
  • Requirements of other agencies
    • State
    • Federal

Who Will Benefit:

  • Associates, Specialists, Managers, Associate Directors, Directors of US Pharma Industry

Instructor Profile:

Peggy Berry

Peggy Berry
Founder, Synergy Consulting LLC

Peggy J. Berry, MBA, RAC, is the President & CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics. Prior to founding Synergy Consulting, she was Vice President of Regulatory Affairs at Insmed where she was responsible for the development and implementation of global regulatory strategies and the management and oversight of the regulatory affairs department. She also worked as Vice President of Regulatory Affairs and Quality at Amarin and held a variety of senior level positions at Dyax, MGI Pharma, AstraZeneca and Dey Pharma. She has also held Regulatory Affairs roles within two clinical contract research organizations and has worked in review divisions at the FDA. In addition, Ms. Berry is active in the Regulatory Affairs Professionals Society. She is an editor-in-chief of Fundamentals of US Regulatory Affairs, 6th edition (RAPS, MD 2010). Editor of “Choosing the Right Regulatory Career” (RAPS, MD 2010) and author of “Communication & Negotiation” (RAPS, MD 2011).

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

More Events From Same Organizer

Venue Map